Ambrosia Biosciences takes over ex-Pfizer space in Boulder
Company boosts Series A round to $25M

Ambrosia Biosciences has moved into Pfizer's previously shuttered Boulder research and development facilities.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Already have a paid subscription?